Bavarian Nordic

2024 - 8 - 13

Bavarian Nordic: Den Danske Biotech Superhelt, der Redder Afrika!

Mpox -- monkeypox Africa CDC - Bavarian Nordic - Chikungunya vaccine - Global health equity - Mpox vaccine - Public health emergency - WHO - Mpox - monkeypox

Bavarian Nordic trækker i den grønne kappe og donerer mpox-vacciner til Afrika – hvad er der mere i vente?

Den danske biotech virksomhed Bavarian Nordic har for nylig annonceret deres beslutning om at donere hele 40.000 doser af mpox-vaccinen til Afrika CDC, efter at der er rapporteret om en alarmerende stigning i mpox- tilfælde på kontinentet. Direktøren for Afrika CDC, Dr. Jean Kaseya, har opfordret til større opmærksomhed omkring det stigende antal tilfælde, der ifølge ham i høj grad er blevet ignoreret. Vaccinen, der bekæmper monkeypox og tager sigte på at beskytte de mest sårbare grupper, er eftertragtet, især i lyset af den nuværende sundhedskrise.

Bavarian Nordic har også modtaget Priority Review-status fra den amerikanske FDA for deres chikungunya-vaccine, som forventes at få afgørelse i februar 2025. Denne vaccine vil bringe endnu en trussel under kontrol, da chikungunya er en virus, der ofte forårsager alvorlige symptomer og har en stor indvirkning på folks liv og sundhed. Den nye vaccine vil således bidrage til at beskytte befolkningen både i Danmark og globalt.

Aktierne i Bavarian Nordic er steget markant efter, at den Europæiske Kommission indgik en ordre på MVA-BN mpox-vacciner, som vil blive sendt til Afrika for at hjælpe med at bremse udbruddet af mpox. Med mere end 37.000 rapporterede mpox-tilfælde og over 1.400 dødsfald siden begyndelsen af 2022, er det altafgørende, at vi adresserer denne sundhedstrussel med hurtige og effektive tiltag.

Men vidste du, at Bavarian Nordic ikke kun fokuserer på vacciner? De er også dybt involveret i forskning indenfor kræftbehandlinger og virusinfektioner, hvilket demonstrerer deres alsidige tilgang til sundhed og sygdomsbekæmpelse. Det er klart, at Bavarian Nordic leverer ikke blot til det danske marked, men bidrager aktivt til verdens sundhed og sikkerhed i kampen mod infektionssygdomme, og deres produkter og forskning har potentiale til at redde utallige liv.

Så næste gang du hører om en dansk virksomhed, så husk at Bavarian Nordic er en superstjerne, der ikke kun skal fejres her i Danmark, men også globalt! De gør en forskel hver dag, og deres dedikation til innovation og global sundhed viser, at bioteknologi er mere relevant end nogensinde.

I et liv, der ofte er fyldt med ubesvarede spørgsmål om sundhed og sygdom, kan vi være glade for, at virksomheder som Bavarian Nordic står i spidsen for innovation og hjælper med at finde svar - og pas på os alle!

Post cover
Image courtesy of "pharmaceutical-technology.com"

Bavarian Nordic outlays 215000 mpox vaccine dose supply to ... (pharmaceutical-technology.com)

Africa CDC's director general Dr. Jean Kaseya stated the number of rising mpox cases in the continent has been “largely ignored”.

Post cover
Image courtesy of "MedWatch"

FDA grants Bavarian Nordic vaccine priority review status (MedWatch)

The vaccine offers protection against the chikungunya virus, and will now be approved or rejected by the FDA by February 2025.

Post cover
Image courtesy of "africacdc.org"

European Commission coordinates procurement and donation of ... (africacdc.org)

In addition, the pharmaceutical company Bavarian Nordic will donate 40 000 doses to HERA. The Africa CDC will distribute the vaccines according to regional ...

Bavarian Nordic to donate mpox vaccine doses following African ... (PharmaLive)

Danish biotech firm Bavarian Nordic said on Tuesday it will donate 40000 doses of its mpox vaccine to Africa's top public health body, after the body ...

Post cover
Image courtesy of "Seeking Alpha"

Bavarian Nordic jumps after EU order for mpox shots (Seeking Alpha)

Bavarian Nordic (BVNRY) stock jumps stock rises as European agency purchases MVA-BN mpox vaccine for Africa amid monkeypox outbreak. Read more here.

Post cover
Image courtesy of "PrecisionVaccinations"

215420 Mpox Vaccines Target Africa's Outbreak (PrecisionVaccinations)

Since the beginning of 2022 and as of late July 2024, a total of 37583 mpox cases and 1451 deaths (case fatality rate 3.9%) have been reported from 15 ...

Post cover
Image courtesy of "Reuters"

Mpox vaccines likely months away even as WHO, Africa CDC ... (Reuters)

Vaccines to help curb an escalating mpox outbreak in Democratic Republic of Congo and neighbouring countries may still not reach the central African country ...

Post cover
Image courtesy of "PrecisionVaccinations"

Second Chikungunya Vaccine Coming in 2025 (PrecisionVaccinations)

With one approved chikungunya vaccine already available, the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the ...

Post cover
Image courtesy of "The New York Times"

W.H.O. Declares Global Emergency Over New Mpox Outbreak (The New York Times)

The epidemic is concentrated in the Democratic Republic of Congo, but the virus has now appeared in a dozen other African countries.

Nordic Shares Rose Wednesday; Bavarian Nordic Led Increases (Morningstar.com)

Stocks in the Nordic region increased Wednesday, with the OMX Nordic 40 Index rising 0.2%. Bavarian Nordic A/S was the biggest leader among large stocks during ...

Bavarian Nordic Says It Can Meet Mpox Shot Demand, Awaits Orders (Livemint)

Bavarian Nordic A/S, one of the few companies with an approved mpox vaccine, says it will be able to meet the immunization needs of African nations in the ...

Post cover
Image courtesy of "Bloomberg"

Bavarian Nordic Says It Can Meet Mpox Shot Demand, Awaits Orders (Bloomberg)

Bavarian Nordic A/S, one of the few companies with an approved mpox vaccine, says it will be able to meet the immunization needs of African nations in the ...

Post cover
Image courtesy of "BNN"

Bavarian Nordic Says It Can Meet Mpox Shot Demand, Awaits Orders (BNN)

Bavarian Nordic A/S, one of the few companies with an approved mpox vaccine, says it will be able to meet the immunization needs of African nations in the ...

Bavarian Nordic Says It Can Meet Mpox Shot Demand, Awaits Orders (Bloomberg Law)

Bavarian Nordic A/S, one of the few companies with an approved mpox vaccine, says it will be able to meet the immunization needs of African nations in the ...

Post cover
Image courtesy of "Financial Times"

WHO declares mpox public health emergency as cases surge in Africa (Financial Times)

Global health body calls for action to tackle 'very worrying' outbreak of highly transmissible virus.

Bavarian Nordic, other health stocks jump on Mpox concerns (Yahoo Finance)

(Bloomberg) -- Shares of Danish vaccine developer Bavarian Nordic A/S jumped, while other medical product makers also rose, after the World Health ...

Explore the last week